stockrowBionano Genomics, Inc. (BNGO) vs NexGel, Inc. (NXGL)
- Bionano Genomics, Inc. BNGO 1.14 +3.64%
- NexGel, Inc. NXGL 3.73 −9.47%
Bionano Genomics, Inc. and NexGel, Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $15.4M against $12.7M — 1.2× the size. Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against 3.38%. NexGel, Inc. has the higher net margin (−51.3% vs −106.6%) and the higher return on invested capital (−45.3% vs −81.7%). Across the 18 metrics below, NexGel, Inc. leads on 10 and Bionano Genomics, Inc. on 8.
Valuation
Profitability
| Metric | BNGO | NXGL | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 47.51% | 35.08% | 53.60% |
| Operating margin | (106.67%) | (44.77%) | 1.97% |
| Net margin | (106.58%) | (51.26%) | 0.00% |
| Free cash flow margin | (67.87%) | (27.66%) | 2.36% |
| Return on equity | (83.56%) | (117.57%) | 0.00% |
| Return on assets | (52.04%) | (34.21%) | 0.00% |
| Return on invested capital | (81.68%) | (45.29%) | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack